Long-Term Normal Renal Function after Drastic Weight Reduction in Patients with Obesity-Related Glomerulopathy by Serra, Assumpta et al.
 © 2015 S. Karger GmbH, Freiburg
1662–4033/15/0083–0188$39.50/0 
 Original Article 
 Obes Facts 2015;8:188–199 
 Long-Term Normal Renal Function after 
Drastic Weight Reduction in Patients with 
Obesity-Related Glomerulopathy 
 Assumpta Serra a    Anna Esteve b    Maruja Navarro-Díaz a    Dolores López c    
Ioana Bancu a    Ramón Romero a 
 a  Department of Nephrology, Hospital Universitari Germans Trias i Pujol, Universitat 
Autònoma de Barcelona,  Badalona , Spain;  b  Department of CEESCAT, Hospital Universitari 
Germans Trias i Pujol, Universitat Autònoma de Barcelona,  Badalona , Spain;  c  Department of 
Pathology, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, 
 Badalona , Spain
 
 Key Words 
 Bariatric surgery · Hypertension · Obesity · Kidney disease · Proteinuria 
 Abstract 
 Aims:  No long-term studies of renal function evolution in morbidly obese (MO) patients after 
weight loss are available. The aim of our work was to ascertain the long-term influence of 
drastic weight reduction on renal function in MO patients with obesity-related glomerular le-
sions.  Methods:  92 MO patients with normal renal function and biopsy evidence of mild obe-
sity-related glomerulopathy underwent bariatric surgery (BS) and subsequent drastic weight 
loss. A long-term prospective follow-up (mean duration: 76 ± 42 months) was carried out. 
Basal renal biopsies and basal and long-term metabolic and renal function studies were per-
formed in all cases. Linear mixed models were applied.  Results:  Blood pressure dropped ear-
ly after BS and remained stable thereafter. Creatinine clearance and BMI fell in the first 2 years, 
rose slightly after 5 years and then remained stable. Serum creatinine and albuminuria de-
creased throughout the follow-up period. Renal function and albuminuria evolution showed 
non-significant differences in relation to the number of glomerular lesions.  Conclusions: 
 Drastic weight loss in BS-treated MO patients with pre-surgical normal renal function and mild 
obesity-related glomerular lesions is associated with short- and long-term maintenance of 
normal renal function and improvement in both arterial hypertension and albuminuria. 
 © 2015 S. Karger GmbH, Freiburg 
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 Introduction 
 Evidence of a link between obesity and kidney disease is growing  [1] . Observed glomerular 
hyperfiltration, microalbuminuria, and proteinuria could be the earliest manifestations of 
renal involvement in asymptomatic obese patients  [2, 3] . Weight loss achieved with different 
types of surgical or lifestyle methods results in a short- or medium-term improvement in 
proteinuria and microalbuminuria in obese patients  [4, 5] . Nevertheless, the short- or 
medium-term (up to 24 months) effects of weight loss on the glomerular filtration rate (GFR) 
are variable. In obese patients with renal hyperfiltration, the greatest GFR decrease is achieved 
by bariatric surgery  [2–4] . If this hyperfiltration improvement translates into long-term renal 
benefits remains to be seen. On the other hand, the short-term effects of weight reduction on 
GFR in obese patients with chronic kidney disease are quite variable  [4, 5] ; GFR remains 
stable in some patients  [6–8] , whereas there is improvement in others  [9] . Therefore, 
knowledge of the long-term evolution of renal function and/or proteinuria/albuminuria in 
patients undergoing drastic weight reduction is lacking. 
 Several glomerular lesions, e.g., glomerulomegaly, podocyte hypertrophy, mesangial 
matrix increase (MMI) and focal and segmental glomerulosclerosis (FSGS), are associated 
with obesity. These lesions are collectively known as obesity-related glomerulopathy  [10–
14] . The short- and long-term evolution of renal function after weight loss is less well known 
in patients with obesity-related glomerulopathy than in the overall group of obese patients. 
Although some reports exist on the spontaneous evolution of renal function in these patients 
 [11, 15, 16] , studies dealing with weight loss influence on renal function in these patients are 
scarce and include only few cases with short follow-ups and small weight reductions [17–20] . 
Therefore, the long-term evolution of renal function and/or proteinuria/albuminuria in 
morbidly obese patients with obesity-related glomerulopathy undergoing drastic weight 
reduction is unknown. 
 The first aim of our observational study was to describe the long-term evolution of blood 
pressure, renal function, and albuminuria in a cohort of morbidly obese patients with normal 
renal function who were prospectively followed up after bariatric surgery and subsequent 
weight loss. Our second aim was to assess the possible short- and long-term influences of 
obesity-related glomerular lesions on the evolution of blood pressure, renal function, and 
albuminuria. 
 Patients and Methods 
 In a previous study  [12] , 95 morbidly obese patients with normal renal function were investigated. Of 
these, 92 were included in the present study. The patients underwent open bariatric surgery at our insti-
tution between December 2001 and November 2005. They were invited to participate in a study including 
complete clinical and biochemical evaluation before surgery, renal biopsy at the time of surgery, and clinical 
and biochemical long-term follow-up post-bariatric surgery (with at least one clinical and one biochemical 
evaluation after surgery). All patients met the surgery criteria established by the National Institutes of Health 
consensus  [21] . The surgical technique performed was gastric bypass using either the method described by 
Fobi et al.  [22] or that of Salmon  [23] . Both techniques combine a permanent restriction of volume ingested 
(gastroplasty) with moderate or mild food malabsorption.
 No patient was on insulin, lipid-lowering drugs, or oral antidiabetic treatment at the start of the study. 
29 patients were being treated for arterial hypertension (7 with angiotensin-converting enzyme inhibitors 
(ACEIs), 3 with angiotensin II receptor blockers (ARBs), 4 with diuretics, 2 with β blockers, and 13 with ACEIs 
and/or ARBs in combination with other drugs). Antihypertensive drug dosages were reduced (mainly non-
ACEIs and/or ARBs hypotensive drugs) during follow-up to maintain blood pressure within normal levels. 
 Clinical and biochemical studies were conducted prior to surgery and throughout follow-up in all 
patients studied. Blood pressure was measured using a standard mercury sphygmomanometer of appro-
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priate cuff size. Preoperative (basal) and long-term follow-up blood and urine samples were drawn as previ-
ously described  [12] . Serum glucose, HbA1c, total cholesterol, LDL- and HDL-cholesterol, triglycerides, serum 
creatinine, creatinine clearance, and 24-hour albuminuria were measured as previously described  [12] . 
 Renal biopsies were routinely processed for histological studies using standard procedures and image 
analysis techniques to detect the presence of glomerulomegaly  [12] . 
 In order to evaluate the possible influence of glomerular lesions on the evolution of clinical and renal 
function variables throughout follow-up, we selected the most common forms of obesity-related glomerular 
lesions  [11, 12, 14] . Specifically, the lesions selected were MMI and/or FSGS, glomerulomegaly, and podocyte 
hypertrophy. MMI was considered to be present when mesangial sclerosis causing diffuse widening of the 
mesangium was identified, while FSGS was diagnosed when focal and segmental consolidation of the 
glomerular tuft by increased extracellular matrix with obliteration of capillary lumina was identified. On the 
other hand, the diagnosis of glomerulomegaly required the glomerular area to be above the mean glomerular 
area plus two standard deviations (SD) in a control group of normal-weight subjects  [12] and the absence of 
other renal lesions, while podocyte hypertrophy was diagnosed when podocyte enlargement with large 
nuclei and prominent nucleoli, with or without intracytoplasmic protein resorption droplets, was present in 
the absence of any other renal lesion.
 Our patients were classified in 3 different histological groups according to the number of lesions of 
obesity-related glomerulopathy presented: no lesion, 1 lesion and 2–3 lesions. For statistical reasons, we 
considered patients with 2–3 lesions to be in the same histological group.
 High office systolic (SBP) and diastolic blood pressures (DBP) were defined as  ≥ 140 mm Hg and 90 mm 
Hg, respectively, in two different measurements with an appropriate arm-cuff. Arterial hypertension was 
considered to be present when the patient had either high office SBP or DBP readings or was being treated 
with hypotensive drugs. Diabetes mellitus, hypercholesterolemia, and hypertriglyceridemia were defined as 
previously described  [12] . Glomerular hyperfiltration was considered to be present when creatinine 
clearance was >140 ml/min. Microalbuminuria was defined as albumin levels between 30 and 300 mg in 
24-hour urine.
 Statistical Analysis  
 To test for differences in proportions among patients according to the number of glomerular lesions, we 
used the Pearson’s chi-square test, applying continuity correction or Fisher’s exact test as appropriate. The 
Kruskal-Wallis test was used to compare medians of continuous renal variables among patient groups. To 
analyze changes between consecutive time points (baseline as well as 2, 5, 7 and 9 years), Mc Nemar’s test 
and the Wilcoxon signed-rank test (paired tests) were used for binary and continuous variables, respectively. 
Linear mixed models were considered to assess the long-term 7-year effects of the number of obesity-related 
glomerular lesions on SBP, DBP, serum creatinine, creatinine clearance, and 24-hour albuminuria. The linear 
mixed models permitted the analysis of longitudinal data, taking into account the existing correlation 
between the repeated measures within each patient. All models were adjusted according to the patient’s BMI 
evolution during follow-up. The regression coefficient of the time term (in years) in each of the linear mixed 
models was interpreted as the mean change per year of the corresponding renal variable. To assess differ-
ences between groups of patients according to the number of glomerular lesions, an interaction term was 
included in the model (number of lesions × BMI). A significant p value of the regression coefficient of the 
interaction term meant different slopes (mean changes per year) in patients with a different number of 
glomerular lesions. Statistical analyses were made with the SAS 9.1 (SAS, Cary, NC, USA) package.
 Results 
 General Data at Baseline, Short-Term Follow-Up, and Long-Term Follow-Up 
 Clinical, biochemical and histological data of all 92 morbidly obese patients at the time of 
renal biopsy (baseline) are shown in  table 1 . Mean BMI was 53.9 ± 9.1 kg/m 2 . All patients had 
normal renal function tests.
 When the 92 patients were subdivided according to the number of obesity-related 
glomerular lesions they presented, 17 had no lesion, 34 had 1 lesion (11 only podocyte hyper-
trophy, 6 only glomerulomegaly, and 17 only MMI and/or FSGS), 31 patients had 2 lesions (13 
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MMI and/or FSGS and podocyte hypertrophy, 16 MMI and/or FSGS and glomerulomegaly, 
and 2 glomerulomegaly and podocyte hypertrophy), and 10 patients had 3 lesions (MMI and/
or FSGS, glomerulomegaly, and podocyte hypertrophy). 
 The short- and long-term evolution of clinical, metabolic and renal function data of our 
cohort and of treatment with ACEIs and/or ARBs drugs are shown in  table 2 . Mean BMI and 
creatinine clearance decreased significantly during the first 2 years of follow-up, increased 
between 2 and 5 years after surgery, and remained stable thereafter. Mean SBP and DBP fell 
significantly during the first 2 years after bariatric surgery and remained stable thereafter. 
Mean serum creatinine and 24-hour albuminuria decreased throughout the first 7 years of 
follow-up. All metabolic indicators improved significantly during the first 2 years post-
surgery. Improvement in HDL-cholesterol levels persisted for 5 years following surgery. 
Increases in serum total cholesterol, glucose and HbA1c were observed in the long-term 
follow-up. 
 No short- or long-term differences in relation to serum creatinine and creatinine clearance 
were observed between patients who presented with basal 24-hour albuminuria  ≥ 30 mg / 
24 h or with basal 24-hour albuminuria < 30 mg / 24 h. 
 Differences in Anthropometric and Renal Function Variables at Various Follow-Up Points 
(Baseline as well as 2, 5, 7, and 9 Years) according to the Number of Obesity-Related 
Glomerular Lesions ( fig. 1 )  
 At baseline, the three groups of patients (no lesions, 1 lesion, and 2–3 lesions) presented 
significant differences in BMI (p < 0.05), but not in SBP and DBP, serum creatinine, creatinine 
 Table 1.  Anthropometric, clinical, biochemical and histological description of data at the time of renal biopsy 
(baseline)
Total patients (n = 92)
Female gender 58 
A ge, years 41.9 ± 10 (19–58)a 
Body weight, kg 148.5 ± 25.6 (96–220)a
BMI, kg/m2 53.9 ± 9.1 (40.3–80.9)a
Obesity duration, months 238 ± 105b
Time of follow-up, months 76,3 ± 41.6 (6–144)a
Smoker 47 (51%)c
High blood pressure 53 (58%)c
Diabetes mellitus 13 (14%)c
Impaired fasting glucose 20 (22%)c
Hypercholesterolemia 36 (39%)c
Hypertriglyceridemia 25 (27%)c
High glomerular filtration rate 30 (33%)c
Normal glomerular filtration rate 62 (67%)c
Without microalbuminuria 
(24-hour albuminuria <30 mg / 24 h) 50 (55%)c
Microalbuminuria 
(24-hour albuminuria ≥30 and ≤300 mg / 24 h) 38 (41%)c
24-hour albuminuria >300 and <500 mg / 24 h 4 (4%)c
Treatment with ACEIs/ARBs 23 (25%)c
Obesity-related glomerulopathy
No lesions 17 (18%)c
One lesion 34 (37%)c
Two or three lesions 41 (45%)c
 a Mean ± SD and range. b Mean ± SD. c n (%).
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clearance and 24-hour albuminuria. Patients with glomerular lesions had higher BMI than 
patients without glomerular lesions.
 No differences were found among the 3 groups with regard to SBP and DBP, serum creat-
inine, creatinine clearance and 24-hour albuminuria at 2, 5 and 9 years after bariatric surgery. 
Differences were observed at 7 years post-surgery for SBP (p < 0.05) and DBP (p < 0.05) , but 
not in renal function parameters or 24-hour albuminuria.
 Differences in Anthropometric and Renal Function Variables during Follow-Up according 
to the Number of Obesity-Related Glomerular Lesions ( fig. 1 ). 
 Long-term follow-up of BMI, serum creatinine, creatinine clearance, and 24-hour albu-
minuria in patients with no lesions, 1 lesion and 2–3 lesions of obesity-related glomeru-
 Fig. 1.  a Serum creatinine,  b cre-
atinine clearance,  c 24-hour albu-
minuria and  d BMI at baseline, 
and at 2, 5, 7 and 9 years after bar-
iatric surgery in patients with a 
different number of obesity-relat-
ed glomerular lesions (no lesion, 
1 lesion and 2–3 lesions).  
 (a) p value: Kruskal-Wallis test be-
tween groups.  
 (1) p value: signed-rank test, paired 
data within groups. 
(For figure 1c and d see next page.)
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lopathy showed a significant BMI decrease during the first 2 years after bariatric surgery in 
all 3 groups. BMI increased slightly between 2 and 5 years after surgery in patients with 1 
lesion and in patients with 2–3 lesions.
 Serum creatinine dropped significantly in the 3 groups during the early follow-up phase 
and continued to decrease between 2 and 5 years post-surgery in patients with 2 or 3 lesions 
of obesity-related glomerulopathy.
 Creatinine clearance fell significantly early after bariatric surgery and rose between 2 
and 5 years after surgery in patients with 2 or 3 lesions of obesity-related glomerulopathy; 
however, no changes were observed in the other histological groups. 
 1 
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 24-hour albuminuria decreased significantly during early follow-up in patients with 1 or 
more lesions of obesity-related glomerulopathy. A significant 24-hour albuminuria drop was 
seen between 2 and 5 years of follow-up in patients with 2 or 3 glomerular lesions, between 
5 and 7 years after surgery in patients with no lesions, and between 7 and 9 years in patients 
with 1 lesion.
 Long-Term Effects of Obesity-Related Glomerular Lesions on Renal Function Variables 
( table 3 ).  
 The mixed models over a 7-year follow-up period showed the number of obesity-related 
glomerular lesions to be associated with a SBP increase, but not with changes in the other 
variables analyzed (DBP, serum creatinine, creatinine clearance, and 24-hour albuminuria).
 Time and BMI significantly influenced the evolution of renal function and 24-hour albu-
minuria. On the other hand, BMI significantly contributed to the evolution of SBP and DBP. 
 Similar results were obtained when the BMI-adjusted influence of the different numbers 
of obesity-related glomerular lesions on the evolution of blood pressure, renal function, and 
24-hour albuminuria was analyzed over a 9-year follow-up period.
 Discussion 
 This is the first prospective observational study describing the long-term evolution of 
blood pressure and renal function variables in a bariatric surgery-treated cohort of 92 
morbidly obese patients with pre-surgical evidence of obesity-related glomerulopathy, 
normal renal function, and post-surgical weight loss. 
 More specifically, this study is the first to analyze the influence of the number of obesity-
related glomerular lesions on the evolution of blood pressure, renal function, and microalbu-
minuria after adjustment for confounding variables such as BMI changes. 
 Recently, several studies addressed the short-term evolution of renal function and 
proteinuria in obese patients after weight loss  [2, 3, 8, 9, 19, 24–27] , and the results have been 
summarized in several meta-analyses  [4, 5] . Improvements in renal function, proteinuria, and 
albuminuria were the most common findings and occurred in patients with or without estab-
lished chronic renal failure  [5, 18, 28, 29] . These improvements were more pronounced in 
bariatric surgery-treated patients than in those whose weight loss was induced by lifestyle 
methods. This difference was probably due to the easier maintenance of weight loss in 
 Table 3.  Relationship between the number of obesity-related glomerular lesions and clinical and renal function variables after 
7 years of follow-up (longitudinal linear mixed modelsa)
Time, years BMI  Number of lesions p value 
number of 
lesions × BMIbslope (SE) p value slope (SE) p value slope (SE ) p value
SBP –0.02 (0.04) 0.1920 1.05 (0.15) <0.0001 9.5 (3.7) 0.0126 0.0165
DBP –0.02 (0.03) 0.4788 0.49 (0.12) <0.0001 5.0 (3.0) 0.0959 0.1957
Serum creatinine –0.08 (0.03) 0.0008 0.31 (0.11) 0.0046 –3.4 (2.8) 0.2312 0.6063
Creatinine clearance 0.30 (0.08) 0.0003 0.949 (0.35) 0.0076 –0.4 (8.9) 0.9678 0.6753
24-hour albuminuriac –0.004 (0.001) <0.0001 0.007 (0.004) 0.0570 –0.15 (0.1) 0.1333 0.0614
 a Linear mixed models: outcome = intercept + year + BMI + number of lesions + number of lesions × BMI. 
b P value of the interaction term number of lesions × BMI of the adjusted linear mixed model. 
c The variable is transformed as log10.
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bariatric surgery-treated patients. Follow-up periods oscillated between 6 months and 2 
years in the majority of publications, and studies with more prolonged follow-up periods are 
lacking. Therefore, no knowledge exists regarding the long-term renal function evolution in 
morbidly obese patients undergoing drastic weight loss after bariatric surgery, either in cases 
with initially normal or abnormal renal function and with or without albuminuria  [5] .
 We studied long-term renal function evolution after bariatric surgery (mean follow-up > 
6 years) in 92 morbidly obese patients with basal normal renal function without albuminuria 
or with low-range albuminuria. In our work, blood pressure remained within normal limits 
9 years after surgery (with or without antihypertensive treatment), serum creatinine and 
albuminuria decreased over time, and creatinine clearance fell in the first 2 years of follow-
up and rose afterwards in some cases. These long-range discordant results between serum 
creatinine and creatinine clearance could suggest that serum creatinine might not be an 
accurate method for evaluating renal function in patients losing weight. Other factors, such 
as muscle mass loss, could influence creatinine levels more than other renal function vari-
ables. 
 Several factors such as NaCl management, changes in diet type, or food tolerance could 
explain the creatinine clearance decrease observed during the first 2 years post bariatric 
surgery and its later increase. This long-term rise in creatinine clearance was accompanied 
by a slight increase in other variables such as serum HbA1c, total cholesterol, HDL- and LDL-
cholesterol, and triglyceride levels  [30] . As reported in other series of obese or non-obese 
patients, long-term studies of the effects of different diet types on slimmed-down morbidly 
obese patients could help to explain these changes  [31] .
 Since in clinical practice the presence of microalbuminuria is considered a major marker 
for renal damage, we studied whether the presence of basal albuminuria could influence the 
long-term renal function prognosis and found no long-term differences in relation to renal 
function parameters. The early intervention in these patients before they presented 
proteinuria might have avoided a worse renal prognosis. No control studies on this subject 
are available. 
 The prognosis of renal function in obese patients with obesity-related glomerulopathy is 
very poorly known. An unfavorable spontaneous evolution of renal function has been described 
in obese patients with proteinuria and/or renal failure and glomerulomegaly and/or FSGS  [11, 
16] . 15% of these patients had doubled their serum creatinine levels or developed end-stage 
renal disease after 5 years, whereas 45% of them had doubled their serum creatinine levels or 
developed end-stage renal disease after 8 years  [11] . In those studies, the risk of progression 
to renal failure correlated with serum creatinine levels at the time of diagnosis  [16] .
 Little is known on the short- and long-term renal function changes in obese patients with 
obesity-related glomerulopathy undergoing drastic weight reduction. Only a few studies on 
this type of patient with proteinuria and/or abnormal renal function and glomerulomegaly 
and/or FSGS lesions have been published  [18, 19, 32] . Slowing of renal function deterioration 
and decreased proteinuria have been reported in these patients after drastic weight loss  [18, 
19, 32] . However, there are no short- or long-term prospective studies of renal function 
evolution in bariatric surgery-treated morbidly obese patients with pre-surgical evidence of 
normal renal function and obesity-related glomerular lesions and postsurgical drastic weight 
loss. 
 In our bariatric surgery-treated morbidly obese patients with initially normal renal 
function and different types and number of obesity-related glomerular lesions, the long-term 
prognosis was good, regardless of the type of glomerular lesion and the number of glomerular 
lesions observed on renal biopsy. These good results differ from those obtained from the 
historic obese controls with no bariatric surgery  [11, 16] . Blood pressure, renal function, and 
urine albumin levels remained within normal limits throughout the long-term follow-up 
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period, irrespective of the presence or absence of glomerular lesions. Thus, we can assume 
that drastic weight loss exerted a positive influence on the renal prognosis of these patients. 
For ethical reasons, our study did not include a control group of morbidly obese patients in 
spontaneous evolution. Similarly, after adjustment for BMI changes, longitudinal linear mixed 
model analysis demonstrated that the number of obesity-related glomerular lesions did not 
influence the evolution of serum creatinine levels or creatinine clearance. Likewise, the 
evolution of SBP would have been influenced by the number of obesity-related glomerular 
lesions. No similar longitudinal linear mixed model studies of renal function variables in 
morbidly obese patients with obesity-related glomerulopathy exist for comparison with our 
results. 
 The main strength of this long-term observational study lies in the fact that it included a 
large cohort (92 patients) of bariatric surgery-treated morbidly obese patients with renal 
biopsy before drastic weight loss. Surgical techniques used in recent years prevent renal 
biopsies being taken during bariatric surgery which renders our study difficult to repeat.
 We acknowledge several limitations of our ongoing observational study. For example, 
subjects were mainly females, and some patients were treated with ACEIs and/or ARBs, drugs 
that may affect the evaluation of albuminuria (however, the percentage of patients treated 
with these drugs was similar at the beginning and the end of follow-up). Our study (of patients 
selected on the basis of surgical indications) is the only one addressing the long-term renal 
function evolution of patients with normal renal function without albuminuria or with low-
degree albuminuria at baseline. Serum creatinine levels and 24-hour creatinine clearance 
were used to evaluate renal function. GFR was estimated using creatinine clearance measured 
in a 24-hour urine sample without correction for body surface area, since correction would 
considerably underestimate the real value of GFR  [33] . 
 Conclusions 
 Drastic weight loss in bariatric surgery-treated morbidly obese patients with initially 
normal renal function results in an improvement of arterial hypertension and albuminuria 
levels and in a short- and long-term maintenance of normal renal function variables.
 Long-term evolution of renal function and albuminuria was not influenced by the number 
of obesity-related glomerular lesions. The number of glomerular lesions would have nega-
tively affected the long-term course of SBP. 
 Thus, it is reasonable to assume that drastic weight loss and improvement in variables 
such as arterial hypertension contribute to the excellent renal prognosis of morbidly obese 
patients with certain obesity-related glomerular lesions but free of other kidney conditions. 
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 Patients were selected for bariatric surgery following the criteria of our hospital’s Obesity Unit. Renal 
biopsies were obtained when possible, with a maximum of two punctures in each patient. The project was 
approved by the hospital Institutional Review Board (protocol No. EO-00–010). All patients gave their 
written informed consent to participate in the study.
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